DarioHealth Corp.

16.92-1.32-7.24%Vol 112.68K1Y Perf 173.63%
Apr 19th, 2021 11:12 DELAYED
BID16.88 ASK16.96
Open18.25 Previous Close18.24
Pre-Market- After-Market-
 - -%  - -
Target Price
21.40 
Analyst Rating
Strong Buy 1.00
Potential %
24.35 
Finscreener Ranking
★★★★     53.63
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★★+     50.21
Insiders Value % 3/6/12 mo.
-/-/100 
Growth Ranking
★★★     52.97
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Market Cap260.48M 
Earnings Rating
Neutral
Price Range Ratio 52W %
43.23 
Earnings Date
11th May 2021

Today's Price Range

16.8818.52

52W Range

5.5531.85

5 Year PE Ratio Range

-0.7000-1.20

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-11.54%
1 Month
-7.08%
3 Months
1.96%
6 Months
36.83%
1 Year
173.63%
3 Years
-48.18%
5 Years
-82.76%
10 Years
-

TickerPriceChg.Chg.%
DRIO16.92-1.3200-7.24
AAPL134.780.62000.46
GOOG2 304.126.36000.28
MSFT260.02-0.7200-0.28
XOM56.02-0.6400-1.13
WFC43.880.04000.09
JNJ162.750.51000.31
FB304.17-2.0100-0.66
GE13.27-0.1200-0.90
JPM152.37-0.9300-0.61
Financial StrengthValueIndustryS&P 500US Markets
4.30
4.90
0.01
0.02
-
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
33.20
-343.00
-340.50
-311.40
-
RevenueValueIndustryS&P 500US Markets
5.91M
0.38
7.92
41.12
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.62-1.06-70.97
Q03 2020-0.84-0.7115.48
Q02 2020-1.74-0.6761.49
Q01 2020--1.57-
Q03 2019--1.20-
Q02 2019--2.60-
Q01 2019--3.00-
Q04 2018--0.11-
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.9367.93Positive
6/2021 QR-0.9950.00Positive
12/2021 FY-3.33--
12/2022 FY-2.48--
Next Report Date11th May 2021
Estimated EPS Next Report-0.93
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume112.68K
Shares Outstanding15.40M
Trades Count1.15K
Dollar Volume5.74M
Avg. Volume280.29K
Avg. Weekly Volume201.51K
Avg. Monthly Volume308.10K
Avg. Quarterly Volume294.22K

DarioHealth Corp. (NASDAQ: DRIO) stock closed at 18.24 per share at the end of the most recent trading day (a -6.12% change compared to the prior day closing price) with a volume of 243.37K shares and market capitalization of 260.48M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 72 people. DarioHealth Corp. CEO is Erez Raphael.

The one-year performance of DarioHealth Corp. stock is 173.63%, while year-to-date (YTD) performance is 27.64%. DRIO stock has a five-year performance of -82.76%. Its 52-week range is between 5.55 and 31.85, which gives DRIO stock a 52-week price range ratio of 43.23%

DarioHealth Corp. currently has a PE ratio of -4.90, a price-to-book (PB) ratio of 10.83, a price-to-sale (PS) ratio of 49.56, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -106.52%, a ROC of -152.89% and a ROE of -135.89%. The company’s profit margin is -%, its EBITDA margin is -340.50%, and its revenue ttm is $5.91 Million , which makes it $0.38 revenue per share.

Of the last four earnings reports from DarioHealth Corp., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.93 for the next earnings report. DarioHealth Corp.’s next earnings report date is 11th May 2021.

The consensus rating of Wall Street analysts for DarioHealth Corp. is Strong Buy (1), with a target price of $21.4, which is +24.35% compared to the current price. The earnings rating for DarioHealth Corp. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DarioHealth Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DarioHealth Corp. has a Sell technical analysis rating based on Technical Indicators (ADX : 21.97, ATR14 : 2.61, CCI20 : -90.67, Chaikin Money Flow : -0.12, MACD : -1.57, Money Flow Index : 45.35, ROC : -7.18, RSI : 32.31, STOCH (14,3) : 16.33, STOCH RSI : 0.26, UO : 47.23, Williams %R : -83.67), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DarioHealth Corp. in the last 12-months were: Adam K. Stern (Buy at a value of $61 852), Allen Kamer (Buy at a value of $0), Dennis Matheis (Buy at a value of $0), Erez Raphael (Buy at a value of $12 040), Hila Karah (Buy at a value of $0), Yoav Shaked (Buy at a value of $18 420)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

DarioHealth Corp.

DarioHealth Corp is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue by sales of its product.

CEO: Erez Raphael

Telephone: +972 47704055

Address: 8 HaTokhen Street, Caesarea 3088900, , IL

Number of employees: 72

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

46%54%

Bearish Bullish

56%44%

Bearish Bullish

56%44%

News

Stocktwits